Vaccine for treatment and prevention of herpes simplex virus infection
US8541002B2 · kind B2 · utility
13Cited by
71References
43Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 13, 2004 |
| Grant date | Sep 24, 2013 |
| Priority date | — |
| Expiry date | Apr 26, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2710/16671
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to methods and compositions for the prevention and treatment of herpes virus infections. The invention provides antigenic peptides, and pharmaceutical compositions comprising complexes of antigenic peptides and adjuvants that can activate an immune response against herpes viruses. The invention also provides methods of making the antigenic peptides and complexes of antigenic peptides and adjuvants. Methods of use of the pharmaceutical compositions are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.